These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38704598)

  • 21. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.
    Liu Y; Zhang Y; Liu D; Tan X; Tang X; Zhang F; Xia M; Chen G; He L; Zhou L; Zhu X; Liu H
    Kidney Blood Press Res; 2018; 43(6):1852-1864. PubMed ID: 30537719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy.
    Russo E; Drovandi S; Salvidio G; Verzola D; Esposito P; Garibotto G; Viazzi F
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2343-2350. PubMed ID: 32912790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers for the progression of IgA nephropathy.
    Maixnerova D; Reily C; Bian Q; Neprasova M; Novak J; Tesar V
    J Nephrol; 2016 Aug; 29(4):535-41. PubMed ID: 27142988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of the kidney failure risk equation to inform clinical care of patients with chronic kidney disease: a mixed-methods systematic review.
    Bhachu HK; Fenton A; Cockwell P; Aiyegbusi O; Kyte D; Calvert M
    BMJ Open; 2022 Jan; 12(1):e055572. PubMed ID: 35042708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study.
    Shu D; Xu F; Su Z; Zhang J; Chen C; Zhang J; Ding X; Lv Y; Lin H; Huang P
    BMC Nephrol; 2017 Jan; 18(1):11. PubMed ID: 28061828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal Megalin mRNA Downregulation Is Associated with CKD Progression in IgA Nephropathy.
    Wen L; Wang X; Ji F; Wen J; Zhao Z
    Am J Nephrol; 2022; 53(6):481-489. PubMed ID: 35661648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
    Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
    Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining clinical features and MEST-C score in IgA nephropathy may be a better determinant of kidney survival.
    Yeter HH; Gonul I; Guz G; Helvaci O; Korucu B; Akcay OF; Derici U; Arinsoy T
    Rom J Intern Med; 2020 Dec; 58(4):209-218. PubMed ID: 32841168
    [No Abstract]   [Full Text] [Related]  

  • 33. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and histological features and therapeutic strategies for IgA nephropathy.
    Moriyama T
    Clin Exp Nephrol; 2019 Sep; 23(9):1089-1099. PubMed ID: 30968243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
    Haaskjold YL; Lura NG; Bjørneklett R; Bostad L; Bostad LS; Knoop T
    Nephrol Dial Transplant; 2023 May; 38(5):1183-1191. PubMed ID: 35904322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External Validation of the International Prognosis Prediction Model of IgA Nephropathy.
    Hu L; Fang Y; Huang J; Liu J; Xu L; He W
    Ren Fail; 2024 Dec; 46(1):2313174. PubMed ID: 38345077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.
    Jebali H; Ghabi H; Mami I; Kaab BB; Fatma LB; Smaoui W; Haouet S; Mahjouba HB; Hassan M; Hmida FB; Raies L; Zouaghi MK
    Saudi J Kidney Dis Transpl; 2020; 31(6):1366-1375. PubMed ID: 33565449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study.
    Sato Y; Tsukaguchi H; Higasa K; Kawata N; Inui K; Linh TNT; Quynh TTH; Yoshihiko I; Koiwa F; Yoshimura A
    BMC Nephrol; 2021 Jun; 22(1):230. PubMed ID: 34147067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
    Zhu B; Liu WH; Lin Y; Li Q; Yu DR; Jiang F; Tang XL; Du YY; Yin JZ; Li XF; Zhong YZ; Wang WR; Sun Y; Zhang MJ; Gao YC; Yuan CY; Zhu CF; Cheng XX
    Am J Nephrol; 2022; 53(6):455-469. PubMed ID: 35576899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.